SRS Capital Advisors, Inc. - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
SRS Capital Advisors, Inc. ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$6,000
-94.3%
98,472
-84.3%
0.00%
-93.8%
Q2 2022$106,000
-64.2%
629,1720.0%0.02%
-59.0%
Q1 2022$296,000
-17.5%
629,1720.0%0.04%
-15.2%
Q4 2021$359,000
-65.6%
629,1720.0%0.05%
-67.8%
Q3 2021$1,044,000
-0.7%
629,1720.0%0.14%0.0%
Q2 2021$1,051,000
+7.4%
629,172
+2.2%
0.14%
-1.4%
Q4 2020$979,000
+66.2%
615,6590.0%0.14%
+46.5%
Q3 2020$589,000
+50.3%
615,6590.0%0.10%
+41.4%
Q2 2020$392,000
-46.6%
615,659
-65.2%
0.07%
-58.6%
Q1 2020$734,0001,768,1590.17%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders